Moreover, previous study had confirmed that plasma CYFRA21-1 appeared more sensitive for NSCLC diagnosis than other tumor biomarkers such as carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) and progastrin-releasing peptide (ProGRP) [36]. This evidence concerns the gene ENO2 and non-small cell lung carcinoma.